Enhancing Effects of Medium Chain Aliphatic Alcohols and Esters on the Permeation of 6-Carboxyfluorescein and Indomethacin through Rat Skin

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 10, Issue 4, 2003, Pages 289-293

  Seki, Toshinobu ^a   Morimoto, Kazuhiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

6 Carboxyfluorescein; Aliphatic Alcohol; Aliphatic Esters; Indomethacin; Permeation Enhancer; Skin Permeation

Indexed keywords

6 CARBOXYFLUORESCEIN; ALKANOL; ESTER; FATTY ACID; FATTY ACID ESTER; INDOMETACIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HYDROPHILICITY; LIPOPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 0344305419     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/drd_10_4_289     Document Type: Article

References (18)

1. Aungst, B. J., Blake, J. A., and Hussain, M. A. 1990. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7:712-718.
2. Bhatia, K. S., and Singh, J. 1998. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J. Pharm. Sci. 87:462-469.
3. Engblom, J., Engstrom, S., and Jonsson, B. 1998. Phase coexistence in cholesterol-fatty acid mixtures and the effect of the penetration enhancer Azone. J. Control. Rel. 52:271-280.
4. Francoeur, M. L., Golden, G. M., and Potts, R. O. 1990. Oleic acid: Its effects on stratum comeum in relation to (trans)dermal drug delivery. Pharm. Res. 7:621-627.
5. Hatanaka, T., Inuma, M., Sugibayashi, K., and Morimoto, Y. 1990. Prediction of skin permeability of drugs. I. Comparison with artificial membrane. Chem. Pharm. Bull. 38:3452-3459.
6. Inagi, T., and Terada, H. 1983. Effects of nonsteroidal antiinflammatory drugs on the proton exchange reaction between octanol and water: Its correlation with their inhibitions of inflammation and prostaglandin synthesis. Biochem. Biophys. Res. Commun. 113:745-750.
7. Larrucea, E., Arellano, A., Santoyo, S., and Ygartua, P. 2001. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur. J. Pharm. Biopharm. 52:113-119.
8. Lee, C. K., Uchida, T., Kitagawa, K., Yagi, A., Kim, N. S., and Goto, S. 1994. Relationship between lipophilicity and skin permeability of various drugs from an ethanol/water/lauric acid system. Biol. Pharm. Bull. 17:1421-1424.
9. Morimoto, K., Haruta, T., Tojima, H., and Takeuchi, Y. 1995. Enhancing mechanisms of saturated fatty acids on the permeations of indomethacin and 6-carboxyfluorescein through rat skins. Drug Dev. Ind. Pharm. 21:1999-2012.
10. Morimoto, K., Tojima, H., Haruta, T., Suzuki, M., and Kakemi, M. 1996. Enhancing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J. Pharm. Pharmacol. 48:1133-1137.
11. Oshima, T., Yoshikawa, H., Takada, K., and Muranishi, S. 1984. Enhancing effect of absorption promoters on percutaneous absorption of a model dye (6-carboxyfluorescein) as poorly absorbable drugs. I. Comparison of plasma levels after addition of various absorption promoters in rat. J. Pharmacobio-Dyn. 7:648-655.
12. Potts, R. O., and Guy, R. H. 1995. A predictive algorithm for skin permeability: The effects of molecular size and hydrogen bond activity. Pharm. Res. 12:1628-1633.
13. Shin, S. C., Shin, E. Y., and Cho, C. W. 2000. Enhancing effects of fatty acids on piroxicam permeation through rat skins. Drug Dev. Ind. Pharm. 26:563-566.
14. Sinha, V. R., and Kaur, M. P. 2000. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm. 26:1131-1140.
15. Smith, S. W., and Anderson,. B. D. 1995. Human skin permeability enhancement by lauric acid under equilibrium aqueous conditions. J. Pharm. Sci. 84:551-556.
16. Sugibayashi, K., Nakayama, S., Sek, T., Hosoya, K., and Morimoto, Y. 1992. Mechanism of skin penetration-enhancing effect by laurocapram. J. Pharm. Sci. 81:58-64.
17. Walters, K. A. 2002. Dermatological and Transdermal Formulations. New York: Marcel Dekker.
18. Yaginuma, H., Nakata, T., Toya, N., Murakami, T., Yamazaki, M., and Kamada, A. 1981. Rectal delivery of antiinflammatory drugs. I. The influence of antiinflammatory drugs on rectal absorption of beta-lactam antibiotics. Chem. Pharm. Bull. 29:2974-2985.